Atara Biotherapeutics (ATRA) Market Capitalization (2014 - 2026)

Atara Biotherapeutics (ATRA) has reported Market Capitalization for 13 consecutive years, with $172.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Market Capitalization rose 83.28% year-over-year to $172.6 million; the trailing twelve-month figure through Jun 2026 stood at $172.6 million (up 83.28% YoY), and the FY2025 full-year result was $226.9 million, up 127.68% from the prior year.
• Market Capitalization improved to $172.6 million in Q2 2026 per ATRA's latest filing, from $66.6 million in the prior quarter.
• Across five years, Market Capitalization topped out at $867.7 million in Q1 2022 and bottomed at $52.2 million in Q2 2024.
• Historically, Market Capitalization has averaged $224.4 million across 5 years, with a median of $156.8 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Market Capitalization tumbled 82.65% in 2023, then jumped 220.23% in 2025.
• Over 5 years, Market Capitalization stood at $314.6 million in 2022, then sank by 82.65% to $54.6 million in 2023, then surged by 82.58% to $99.7 million in 2024, then surged by 127.68% to $226.9 million in 2025, then retreated by 23.95% to $172.6 million in 2026.
• According to Business Quant data, Market Capitalization over the past three periods registered $172.6 million, $66.6 million, and $226.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.